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ABSTRACT
Ultrasonography examination is an one of examination that can be used to see the abnormality of portal
vein system.
The technology of ultrasonography examination has further developed especially after using of Doppler
ultrasonography which could portray haemodynamic changes from portal vein in liver cirrhosis patient.
From this examination we also could predict bleeding.
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INTRODUCTION
Liver cirrhosis is a chronic liver disease signified by
the presence of fibrosis and nodules. This disorder usu-
ally begins with inflammation, widespread liver necrosis,
formation of connective tissues and regeneration nod-
ules. Changes in the structure of the liver result in changes
in the circulation. Functional liver cirrhosis is classified
into two stadiums, compensation (early/latent cirrhosis)
and decompensation (followed by liver failure and portal
hypertension).1,2
Portal hypertension occurs due to an increase in the
pressure of the portal vein system due to increased re-
sistance of the blood vessels and/or increased portal vein
blood flow.1,3,4
Liver cirrhosis accompanied with portal hypertension
can cause bleeding of the upper gastrointestinal tract
due to rupture of the esophageal varices. Seventy per-
cent of patients with liver cirrhosis will eventually suffer
from portal hypertension and esophageal varices.
Djojoningrat reported a prevalence of gastrointestinal
bleeding due to esophageal varices of 70.2% in RSCM
in the year 1988. Soemarno, et al reported 93% preva-
lence of upper gastrointestinal bleeding due to esoph-
ageal varices and gastropathy.7 The prevalence on ini-
tial bleeding is 36%, and 70% on repeated bleeding.8
Sonography is a diagnostic tool that can be utilized to
diagnose abnormalities of the portal vein system.
Sonographic technology has further developed with the
invention of Doppler combined analysis and standard
color ultrasonography, which can portray haemodynamic
changes in the portal vein in patients with liver cirrhosis
and is currently the most un-invasive technique to evalu-
ate the portal vein blood flow. The sensitivity and speci-
ficity of Doppler ultrasonography is 83% and 93% re-
spectively.11,12
HEMODYNAMIC CHANGES OF THE PORTAL SYSTEM
Portal hypertension is mostly due to liver cirrhosis. In
Indonesia, cirrhosis is most frequently caused by a virus,
while cases abroad are more commonly due to alcohol.
Other causes of portal hypertension include thrombosis,
tumor, etc.1,2,3,4
The portal vein system consists of a venous network
that begins at the superior mesenteric vein, goes through
the portal vein and end at the hepatic vein. Before the
portal vein enters the liver, it branches in two to supply
the right and left hepatic lobe.
As we know, the portal pressure is attained from
changes in the hepatic vein. It ranges between 5-10
mmHg measured using catheterization.1,5,6 Portal hyper-
tension occurs due to an increase of pressure in the por-
tal vein system due to an increase in blood vessel resis-
tance and/or a pathologic increase in portal vein blood
flow.
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Figure 1. Portal vein system and collateral pathways of portal hypertension. Portohepatic to SVC: Peripancreatic (a),  
portosystemic: Gastroesophageal varices (b), paraesophageal vein (c),. Portosystemic to IVC: Gastrorenal (d), paraumbilical  
(e), splenorenal (f), splenoretroperitoneal (g), mesentericocaval (h), paracolic (j), pelvic (k). CV coronary vein; GEV gastroepi- 
ploic vein; IMV inferior mesenteric vein; IVC inferior vena cava; PV portal vein; SMV superior mesenteric vein; SV splenic vein. 
 
 
Changes that occur:1,2,3,4 
1.  Increased blood vessel resistance 
Due to liver fibrosis because of the formation of 
collagen tissues due to liver sinusoid that hardens 
and causes mechanic obstruction 
2.  Increased portal vein blood flow 
Due to vasodilatation of the splanchnic artery be- 
cause of humoral factors (glucagons, NO synthase), 
neurogenic factors, and local mechanisms 
3.  Portosystemic collateral formation 
Due to the mechanism of compensation because  
of pathologic portal blood flow to the heart and its  
resistance; This occurs as a mechanism to reduce 
the pressure of the portal system 
4.  Hyperdynamic condition 
Due to an increase in the level of endogen va- 
sodilators which causes vasodilatation and an even- 
tual increase in plasma volume 
5.  Splenomegaly 
PRINCIPLE OF MEASUREMENT USING THE DOP- 
PLER ULTRASOUND DEVICE 
As we know, increase in the portal pressure occurs  
due to increased blood flow to the portal vein. Thus, we  
could indirectly measure pressure in the portal vein by  
measuring the portal vein blood flow using the Doppler  
echo. 
Similar to the blood vessel system in general, changes  
in venous system pressure is a result of blood flow and  
blood vessel resistance, stated by Ohm’s Laws through 
P = Q x R 
the formula:4,7 
P = Pressure changes 
Q = Blood flow 
R =  Blood vessel resistance  
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Thus, the pressure will increase if there is an 
increase in blood vessel resistance and/or portal 
vein blood flow. On the other hand, the portal 
pressure will drop if there is a reduction in blood 
vessel resistance and/or portal vein blood flow. 
Increased blood vessel resistance is caused 
by liver fibrosis that creates an 
obstruction/constriction, thus increasing the 
speed of blood flow, as stated in Pouseuille’s 
theorem, with the formula:4,7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
R = resistance 
N = coefficient of viscosity 
L = blood vessel length 
r = blood vessel radius 
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Figure 3. Doppler echo ultrasonography. Portrays 
increased blood flow through a narrowing tube 
 
 
 
 
 
 
Liver cirrhosis 
Increased resistance of the portal vascular system 
portal hypertension 
porto-systemic shunt 
reduced blood flow to the liver endotoxin 
glucagon vasodilator degradation glucagon induction of NO-synthase 
reduced resistance of splancnic arteriole 
vasodilation
increased splanchnic blood f low
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Figure 2.  Scheme of the  formation of portal hypertension
  8  L 
R =   
  r 4 
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N = coefficient of viscosity
L = blood vessel length
r = blood vessel radius
Using Doppler echo ultrasonography portrays not only
the liver and the portal vein diameter, but also the char-
acteristics of the blood vessel and blood flow, by mea-
DOPPLER ULTRASOUND MEASUREMENT IN PA-
TIENTS WITH PORTAL HYPERTENSION
1. Measurement technique and requirements:9,13,14,15,16
a. The patient must have fasted prior to the exami-
nation.
b. The patient is not allowed to drink medication
that would reduce the pressure of the portal vein,
obstruct the H pump, or H2 receptor antagonist.
c. Supine position. The examination is carried out
with the patient in supine position.
d. The patient must rest for at least 15-30 minutes
prior to the examination.
e. The transducer is placed at a less than 60o angle
to the portal vein before it branches to the right
and left lobe, exactly below the hepatic artery17
or above the inferior vena cava.18
f. Measurements are taken while holding the breath
for 4 seconds.
g. A minimum of  3 measurements are taken and
the values averaged.
2. Measurement of the portal vein system
Measurement of the diameter:
Lafortune et al conducted the following experi-
ment in which the portal vein pressure of 64 patients
with cirrhosis was measured using angiography, while
the diameter was measured using ultrasonography.
From this experiment they found no relationship
between increased portal pressure and the diameter
of the portal, superior mesenteric or splenic veins,
but a change was noticed in the diameter of the coro-
nary vein.
A coronary vein with diameter of more than 0.7
Cm could signify severe portal hypertension
Measurement of the direction of the flow:20
Gaiani et al studied 15 patients with hepatofetal
flow and 29 patients with hepatofugal flow based on
examination using Doppler ultrasound. These patients
were followed for an average of 13 months, to dis-
cover the relationship between the direction of blood
flow and survival rate and risk of bleeding.
After follow up, they found that there was no
relationship in the survival rate of the two groups,
but the risk of bleeding was very high in patients
with hepatofetal blood flow.
3. Evaluation of bleeding 7
Soemarno et al measured the flow and the ve-
locity of portal vein blood flow in 115 men and 39
women with upper gastrointestinal bleeding from the
Emergency Unit of St. Carolus Hospital.
They found that the velocity of flow in 32 pa-
     C Fdmax 
Portal vein velocity =                Cm/sec 
    2 Fo. Cos α 
 
 
Figure 4. The formula to obtain the rate of portal vein blood
flow
suring the speed of the portal vein flow using a certain
technique. After the portal vein diameter is attained, we
could obtain the rate of portal vein blood flow using a
certain formula.
Note:
C = ultrasound wave velocity (1.5 x 105 Cm/sec)
Fdmax = maximum Doppler frequency shift
Fo = ultrasound wave frequency (3.5 Mhz)
α = angle between Doppler beam and the direction of
portal vein flow
Important notes:
1. α has to be less than 60o
2. The state of the following blood flows:
- Hepatopetal: flow towards the liver, must be nor-
mal. For example: blood flow from the portal vein
to the liver.
- Hepatofugal: flow away from the liver, reverse
flow, often found in portal hypertension.
3. No or minimal ascites.
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tients who suffered from bleeding of the esophageal
varices and portal hypertension gastropathy was 14-
18 Cm/sec. The velocity of flow in 14 patients with
gastric bleeding was above 19 Cm/sec.
They concluded that a portal vein velocity above
8 Cm/sec signifies portal hypertension. A portal vein
velocity above 9 Cm/sec signifies high risk of upper
gastrointestinal bleeding. A portal vein velocity above
14 Cm/sec means upper gastrointestinal bleeding
could result from esophageal varices or portal hy-
pertension gastropathy. Thus, we could predict bleed-
ing.
4. Diurnal variation21
Alvarez et al conducted an experiment on diur-
nal fluctuation in 12 patients with liver cirrhosis, 10
men and 2 women ages 30-71 years. The patients
were admitted to the hospital and the hemodynamic
condition and blood flow was evaluated using Dop-
pler ultrasound every 4 hours for 24 hours, and taken
at least 2 hours after meals and after 30 minutes of
rest in supine position. They found that the cardiac
output and portal vein blood flow increased at mid-
night.
The mechanism of such increase in portal vein
blood flow is still unknown. It is possible that this
variation is due to humoral and neurogenic factors,
which are an increase in the vasodilator component
rhythm VIP (vasoactive intestinal peptide), a strong
endogenous vasodilator which peaks at midnight, or
a reduction in sympathetic activity due to reduced
secretion of cathecolamine at midnight.
The variation of portal vein blood flow especially
at midnight explains why the incident of varicose
bleeding is highest at night.
Table 1.  Measurement of the portal vein system in five groups of cirrhosis patients and one 
control group19 
 
Patient 
Group 
(n) 
 
n 
Portohepatic 
Pressure  
(mmHg) 
Portal 
Vein 
Diameter 
(Cm) 
Diameter of 
The Superior 
Mesenteric 
Vein  
(Cm) 
Diameter of 
The Splenic 
Vein (Cm) 
Diameter of 
The Coronary 
Vein (Cm) 
1 4 2,6 ± 1,5 
(0-6) 
2,1 ± 0,3 
(1,6-2,4) 
1,9 ± 0,2 
(1,8-2,2) 
1,5 ± 0,5 
(1-2,2) 
0,47 ± 0,21 
(0,2-0,7) 
2 15 8,9 ± 1,1 
(>6-10) 
1,9 ± 0,2 
(1,4-2,3) 
1,7 ± 0,2 
(1-2) 
1,3 ± 0,3 
(0,8-1,7) 
0,8 ± 0,13 
(0,3-0,7) 
3 15 13,5 ± 1,5 
(>10-15) 
1,8 ± 0,3 
(1,2-2,3) 
1,6 ± 0,2 
(1,2-1,9) 
1,3 ± 0,3 
(0,6-1,8) 
0,72 ± 0,21 
(0,4-1,2) 
4 15 18,5 ± 1,3 
(>15-20) 
1,9 ± 0,2 
(1,4-2,3) 
1,7 ± 0,2 
(1,3-2) 
1,3 ± 0,2 
(1-1,8) 
0,79 ± 0,3 
(0,3-1,7) 
5 15 22,6 ± 1,3 
(>20-25) 
1,6 ± 0,3 
(1,1-2) 
1,6 ± 0,3 
(1-2) 
1,3 ± 0,3 
(0,8-1,8) 
0,7 ± 0,23 
(0,2-1) 
Control 32 - 1,8 ± 0,3 
(1-2,2) 
1,5 ± 0,3 
(1-2) 
1,1 ± 0,3 
(0,8-1,5) 
 
 
      Table 2. Systemic parameter and portal hemodynamic in 12 patients with cirrhosis21 
24 hrs Observation Parameters 
 0800 1200 1600 2000 2400 0400 
Pulse rate 
(pulse/minute) 
77 ± 4 77 ± 4 78 ± 4 79 ± 4 78 ± 4 78 ± 4 
Mean arterial 
pressure (mmHg 
90 ± 12 90 ± 11 88 ± 12 89 ± 12 89 ± 13 90 ± 10 
Cardiac output 
(l/minute) 
6,2 ± 0,6 6,2 ± 0,8 6,3 ± 0,8 6,3 ± 0,7 6,8 ± 0,7 6,6 ± 0,9 
Peripheral blood 
vessel resistance 
(dyne sec cm-5) 
1170 ± 230 1165 ± 200 1110 ± 
221 
1145 ± 
224 
1050 ± 
228 
1080 ± 197 
Portal vein blood flow 
(mm/mnt) 
603 ± 110 680 ± 79 632 ± 
179 
631 ± 
169 
917 ± 
248 
697 ± 178 
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tients with liver cirrhosis. Measurements were taken
using Doppler ultrasonography first during fasting and
the second time 60 minutes after taking a  standard
Italian meal (1100 calories = 18% protein, 39% fat,
43% carbohydrate)
This experiment showed an increase in portal vein
blood flow in normal patients, patients with chronic
hepatitis and those with cirrhosis, but the increase in
cirrhosis patients was not very large.
Increase of blood flow, influenced by meals was
due to both intrinsic mechanisms, which are increased
transmural arteriole pressure and increased vasodi-
lator agents,  extrinsic mechanisms, such as the au-
tonomic nervous system, as well as the influence of
the gastrointestinal hormones gastrin and glucagon.
From this study, we conclude that meals can cause
increased portal vein blood flow, consequently in-
creasing portal pressure.
6. Evaluation of therapy
1. Experiment using pitressin and ranitidine:14
Ohnishi  et al studied 15 men and 4 women
with portal hypertension. Measurements were
taken using both angiography and Doppler ultra-
sound. The portal vein blood flow was measured
before and after therapy. Several patients re-
ceived intravenous pitressin 0.3 U/minute for 15
minutes, and the others received intravenous
ranitidine 50 mg/30 minutes.
They found that there was a reduction in por-
tal vein blood flow after administration of both
pitressin and ranitidine. Similar results were ob-
tained using angiography and Doppler ultrasound
using the formula Y = 0.6 X – 1.723 (Y = an-
giography and X = Doppler ultrasound).
Doppler ultrasonography is sufficiently accu-
      Table 3. The effect of a standard meal on portal vein blood flow velocity22 
 Prior to meals After meals % of icrease 
NS(n = 12) 16 ± 4,1 19,7 ± 4,8 24 
CAH (n = 11) 17,3 ± 4,1 20,4 ± 4,9 18,2 
LC (n = 11) 
 12,4 ± 2,3 12,7 ± 3,1 3,2 
   NS = Normal patients; CAH = Chronic Active Hepatitis; LC = Liver Cirrhosis  
Table 4. Portal vein velocity in 12 patients with portal hypertension, before and after administration of 
pitresin and ranitidine14 
 
  Portal Vein Velocity (cm/sec) Portal Vein Flow 
Patient 
Number 
 
Therapy 
 
Cineangiogra
phy Method 
USG Doppler 
Method 
    
  before after 
 
before after 
 
ml/minute ml/minute/kg ml/minute ml/minute/kg 
1 Pitresin 9,9 3,3 19,5 7,7 499 8,6 156 2,7 
2 Pitresin 9,3 5,4 18,2 12,5 859 12,1 484 6,8 
3 Pitresin 3,8 3,0 9,8 6,4 216 3,7 153 2,6 
4 Pitresin 12,2 4,9 21,9 12,1 622 9,3 232 3,5 
5 Pitresin 8,2 2,4 16,2 5,0 556 8,7 153 2,4 
6 Pitresin 9,2 3,1 17,9 8,4 469 7,2 134 2,1 
7 Pitresin 8,1 2,8 15,2 6,2 705 10,8 203 3,1 
8 Ranitidine 6,2 6,4 14,3 14,6 442 6,2 449 6,3 
9 Ranitidine 9,6 10,3 16,1 17,6 742 9,5 791 10,1 
10 Ranitidine 11 11,0 19,9 20,9 743 14,6 743 14,6 
11 Ranitidine 10,4 10,3 20,4 19,8 705 12,4 698 12,2 
12 Ranitidine 5,1 4,1 13,2 12,5 407 6,6 327 5,3 
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rate to measure portal vein flow and could also
be utilized to observe hemodynamic changes of
the portal pressure.
2. Experiment using propanolol:15
Ohnishi et al studied 12 men and 3 women,
aged 31-71 years, 13 with liver cirrhosis and 1
with hepatoma. Measurements were taken si-
multaneously using catheterization and Doppler
ultrasound. Measurements were taken before
and after administration of 5 mg of propanolol
intravenously for 35 minutes. There was a de-
crease in pulse rate (-12.6%), reduced cardiac
output (-24.5%) and reduced hepatic blood flow
(-27.3%).
Propanolol reduces the portal vein pressure
by reducing portal vein blood flow. This is due to
decreased cardiac output caused by a blockage
of the B1 adrenergic receptor.
CONCLUSION
1. The Doppler ultrasound was used as a method to
evaluate the presence of portal hypertension.
2. The Doppler ultrasound is currently the most un-in-
vasive technique to assess portal vein blood flow.
3. The Doppler ultrasound could be used as a non-in-
vasive method to evaluate changes in the hemody-
namic condition of the portal vein due to medication
or other causes.
4. Using Doppler ultrasound, we can predict bleeding.
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